Carbohydrate loading for diabetic patients undergoing heart surgery
Official title: Efficacy of Carbohydrate Loading in Diabetic Type 2 Patients Undergoing CABG Surgery on CPB
Run by Damascus University · NCT06951308 · Data updated 2026-11-12
This study is testing if eating carbohydrates before heart surgery can help people with type 2 diabetes recover better and have fewer complications.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Damascus University Academic / other |
| Locations | 1 site (Damascus) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | April 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 1, 2026 |
| Trial ID | NCT06951308 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are diabetic type 2 patients scheduled for isolated on-pump coronary artery bypass surgery.
✕Probably not a fit
Patients with type 1 diabetes or those undergoing other cardiac surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effects of carbohydrate loading on diabetic type 2 patients undergoing coronary artery bypass grafting (CABG) surgery. Patients will be randomly assigned to receive either carbohydrate loading two hours before surgery or follow a standard fasting protocol. The study aims to assess the impact of carbohydrate loading on insulin resistance, clinical outcomes such as infection rates and ICU stay duration, and changes in inflammatory markers. By focusing on this specific population, the trial seeks to fill the knowledge gap regarding the efficacy of carbohydrate loading in diabetic patients.
Why it matters
Potential benefit: If successful, this approach could improve recovery outcomes and reduce complications for diabetic patients undergoing heart surgery.
How similar studies have gone: While carbohydrate loading has shown benefits in non-diabetic patients, its efficacy in diabetic type 2 patients undergoing CABG is less understood, making this a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All diabetic type 2 patients undergoing isolated on-pump coronary artery bypass surgery. Exclusion Criteria: * Missing data. * Patients outside the study period. * Patients undergoing other cardiac surgeries. * Patients diagnosed with type 1 diabetes mellitus.
Where it's running
-
Damascus University Cardiac Surgery Hospital
Damascus, Syria Recruiting
Study contacts
- Study coordinator: Mohammad B Izzat, FRCS(CTh)
- Email: mbizzat@gmail.com
- Phone: +963943240820
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease
This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
QFR-guided virtual stenting to optimize PCI before the procedure
We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.
-
LONG NAGOMI PMCF: follow-up of the Ultimaster Nagomi stent in long coronary artery lesions
This project tests the Ultimaster Nagomi drug-eluting stent in adults undergoing PCI for long coronary lesions to collect real-world safety and effectiveness data.
-
Eurosets arterial and venous cannulas for cardiopulmonary bypass procedures
This trial will test Eurosets arterial and venous cannulas during cardiopulmonary bypass in adults having elective coronary or aortic valve surgery to see if they are as safe and work as well as Medtronic cannulas.
-
Endocardial delivery of stem-cell derived heart cells to help severe heart failure
This study tests endocardial delivery of HS-001 cell sheets made from iPSC-derived cardiomyocytes in adults with severe heart failure and reduced ejection fraction to see if it is safe and may improve heart function over 26 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.